Pharmacists’ Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacists’ Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study ; day:27 ; month:6 ; year:2020 ; pages:1-10
Infectious diseases and therapy ; (27.6.2020), 1-10
- Creator
-
Almulhim, Abdulaziz S.
Al-Dahneen, Batool A.
Alsowaida, Yazed S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-020-00310-9
- URN
-
urn:nbn:de:101:1-2020082319363863967814
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Almulhim, Abdulaziz S.
- Al-Dahneen, Batool A.
- Alsowaida, Yazed S.
- SpringerLink (Online service)
Other Objects (12)
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance
Development and validation of the prediction score for augmented renal clearance in critically Ill Japanese adults
Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds
The kinetic glomerular filtration rate is not interchangeable with measured creatinine clearance for prediction of piperacillin underexposure in critically ill patients with augmented renal clearance
Increased β-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study
Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
What is New in Augmented Renal Clearance in Septic Patients?
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance
Development and validation of the prediction score for augmented renal clearance in critically Ill Japanese adults
Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds
The kinetic glomerular filtration rate is not interchangeable with measured creatinine clearance for prediction of piperacillin underexposure in critically ill patients with augmented renal clearance
Increased β-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study
Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
What is New in Augmented Renal Clearance in Septic Patients?
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance
Development and validation of the prediction score for augmented renal clearance in critically Ill Japanese adults
Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds
The kinetic glomerular filtration rate is not interchangeable with measured creatinine clearance for prediction of piperacillin underexposure in critically ill patients with augmented renal clearance
Increased β-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study
Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients